Have a personal or library account? Click to login
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor Cover

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor

Radiology and Oncology
Volume 50 (2016): Issue 4 (December 2016)
By: Uros Smrdel,  Mara Popovic,  Matjaz Zwitter,  Emanuela Bostjancic,  Andrej Zupan,  Viljem Kovac,  Damjan Glavac,  Drago Bokal and  Janja Jerebic  
Open Access
|Nov 2016

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.1515/raon-2015-0041 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 394 - 401
Submitted on: Jul 15, 2015
|
Accepted on: Aug 6, 2015
|
Published on: Nov 10, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glioblastoma,
long-term survival,
methyl guanine methyl transferase,
prognostic factor
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2016 Uros Smrdel, Mara Popovic, Matjaz Zwitter, Emanuela Bostjancic, Andrej Zupan, Viljem Kovac, Damjan Glavac, Drago Bokal, Janja Jerebic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 50 (2016): Issue 4 (December 2016)Next article